Press Releases

LEHI, Utah, July 29, 2019 /PRNewswire/ -- Young Living Essential Oils, the world leader in essential oils, announced today the addition of the

CHICAGO, July 29, 2019 /PRNewswire/ -- Health systems have invested millions of dollars in information technology over the past two decades and now have a treasure trove of data. This data holds the promise for leaders at all levels to have a richer understanding of their organization's true performance and take swift action to improve cost of care, quality, outcom

ROCKVILLE, Md., July 29, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that RGN-137, the Company's wound healing product candidate currently the subject of a U.S. clinical trial, is the subject

PITTSBURGH, July 29, 2019 /PRNewswire/ -- "I have observed the problems my brother experiences being color blind," said an inventor from Castroville, Texas. "This inspired me to develop a device through which color blind individuals could have information on the color identity of various objects."

THE VILLAGES, Fla., July 29, 2019 /PRNewswire/ -- Florida Blue is expanding its relationship with The Villages Health to include Florida Blue Medicare Advantage members. The Villages Health is a

CHICAGO, July 29, 2019 /PRNewswire/ -- On August 1st, parent company Script Health (formerly Fiduscript) expands its pilot launch of NaloxoneExc

LAS VEGAS, July 29, 2019 /PRNewswire/ --  Desert Hope Treatment Center, a leading provider of substance use treatment services, is providing the recov

DETROIT, July 29, 2019 /PRNewswire/ -- University of Detroit Mercy (Detroit Mercy) and Wayne State University's (WSU) ReBUILDetroit program recently received a renewal grant of more than $19 million over five years from the National Institutes of Health (NIH). The ReBUILDetroit program works to encourage und

DUBLIN, July 29, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that it has entered into a settlement and license agreement (the agreement) with Amneal Pharmaceuti

DULUTH, Ga., July 29, 2019 /PRNewswire/ -- A veterinary student conducting research into stem cell repair, another studying the use of CAR T cells against canine B cell lymphoma, and a student with an interest in equine neuromuscular disorders and protein aggregate diseases are being recognized for their efforts -- and the promise they hold -- by Boehringer Ingelheim's